Innate Pharma Announces Conference Call and Webcast for First Half 2024 Financial Results and Business Update
Innate Pharma S.A. - American Depositary Shares (IPHA)
Company Research
Source: Business Wire
MARSEILLE, France--(BUSINESS WIRE)--Regulatory News:Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Thursday, September 12, 2024, at 2 p.m. CEST / 8 a.m. EDT, to give an update on business progress during the first half of 2024.Participants during the call will be:Hervé Brailly, Chief Executive OfficerSonia Quaratino, Executive Vice President, Chief Medical OfficerYannis Morel, Executive Vice President, Chief Operating OfficerFrédéric Lombard, Senior Vice President, Chief Financial OfficerArvind Sood, Executive Vice President, President of US OperationsDetails for the Virtual EventThe live webcast will be available at the following link:https://events.q4inc.com/attendee/127231232Participants may also join via telephone using the following registration link: https://registrations.events/direct/Q4I953384196This information can also be found on the Investors section of the Innate Pharma
Show less
Read more
Impact Snapshot
Event Time:
IPHA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IPHA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IPHA alerts
High impacting Innate Pharma S.A. - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
IPHA
News
- Innate Pharma S.A. (NASDAQ: IPHA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.50 price target on the stock.MarketBeat
- 3 Promising Penny Stocks With Market Caps Under US$500M [Yahoo! Finance]Yahoo! Finance
- Innate Pharma Announces First Patient Dosed in Phase 1 Study of Its Nectin-4 Targeting Antibody Drug Conjugate IPH4502 in Selected Advanced Solid TumorsBusiness Wire
- Innate Pharma Announces Nectin-4 Antibody Drug Conjugate Investor and Analyst Event in New York [Yahoo! Finance]Yahoo! Finance
- Innate Pharma Announces Nectin-4 Antibody Drug Conjugate Investor and Analyst Event in New YorkBusiness Wire